Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clobazam Add-on Therapy in Dravet Syndrome (Randomized Double-Blind Placebo-Controlled Study)
ChiCTR2400088523Phase 4Not yet recruiting
- Sponsor
- West China Second University Hospital
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Dravet syndrome comparing Clobazam add-on arm with Placebo add-on arm (2 arms). Primary endpoint: Proportion of patients with ≥25%, ≥50%, ≥75% and ≥100% reduction in seizures during the study period. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
clobazam
03
Conditions
Dravet syndrome
Beyond the preview
Go deeper on ChiCTR2400088523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088523.